AOBiome LLC   Report issue

For profit Phase 3
Founded: Newton MA United States (2013)

Organization Overview

First Clinical Trial
2015
NCT02656485
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

AOBiome LLC | AOBiome Therapeutics